Ryan Allway November 6th, 2020 Exclusive, German, Psychedelics Die meisten Pharma- und Biotech-Investoren sind mit langen Kommerzialisierungsfristen vertraut, aber es gibt einige Möglichkeiten, diese zu verkürzen. Beispielsweise bietet die Food and Drug Administration für bestimmte Therapien, die auf lebensbedrohliche Erkrankungen abzielen, Bezeichnungen wie Fast Track, Durchbruchstherapie, beschleunigte Zulassung und... Read more
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any... Read more
Ryan Allway November 4th, 2020 App, Exclusive, Psychedelics, Top Story Most pharmaceutical and biotech investors are familiar with long commercialization timelines, but there are a few ways to shortcut the process. For example, the Food and Drug Administration provides Fast Track, Breakthrough Therapy, Accelerated Approval and Priority Review designations... Read more
MagicMed Industries Announces Agreements with the University of Calgary to Accelerate Development of the MagicMed Psybrary™
October 30, 2020
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any... Read more
Wie groß ist die psychedelische Gelegenheit?
October 29, 2020
Ryan Allway October 29th, 2020 German, Psychedelics Der nordamerikanische Markt für psychedelische Medikamente wird vorraussichtlich bis 2027 6.85 Milliarden USD erreichen, nach Daten der Data Bride Market Research, das entspricht einer jährlichen Wachstumsrate von 16.3%. Nach der Genehmigung von Johnson & Johnsons (NYSE: jnj) SPRAVATO Nasenspray für behandlusngsresistente Depressionen... Read more
Delic Corp. Enters into Definitive Agreement for Reverse Takeover of Molystar Resources Inc.
October 26, 2020
Ryan Allway October 26th, 2020 Psychedelics Molystar Resources Inc. (“Molystar” or the “Company“), Delic Corp. (“Delic“), a Delaware-incorporated psychedelic-focused media, e-commerce and event company, and Eception Ventures Ltd. (“Eception“) are pleased to confirm, further to Molystar’s press release dated August 31, 2020 (the “Previous Press Release“), a business combination... Read more
Pharmather Secures Exclusive Rights to Novel Microneedle Delivery Technology for Psychedelic Pharmaceuticals
October 23, 2020
Ryan Allway October 23rd, 2020 Psychedelics Pharmather Inc., a wholly-owned subsidiary of Newscope Capital Corporation (“Pharmather” or the “Company”) (CSE: PHRM) and a specialty life sciences company focused on the research and development of psychedelic pharmaceuticals, is pleased to announce that the Company has entered into an exclusive license... Read more
Numinus Bioscience’s developments include harvesting its first flush of Psilocybe mushrooms at its Health Canada licensed facility. VANCOUVER, BC , Oct. 22, 2020 /CNW/ – Numinus Wellness Inc. (“Numinus” or the “Company”) (TSXV: NUMI), a company creating an ecosystem of health solutions centred on developing and supporting the safe, evidence-based, accessible use of psychedelic-assisted psychotherapies, has... Read more
Ryan Allway October 23rd, 2020 German, Psychedelics Die Psychedelikaindustrie hat das Interesse von Pharmaunternehmen geweckt, die nach sichereren und effektiveren Produkten suchen, um ungedeckte medizinische Bedürfnisse im Bereich der psychischen Gesundheit zu befriedigen. Während psychedelische Moleküle vielversprechend sind, verlangen die Pharmahersteller, dass die Moleküle durch wissenschaftliche Techniken verbessert werden,... Read more
How One Company Is Making Tryptamines & Cannabinoids Greener
October 23, 2020
Ryan Allway October 23rd, 2020 App, Exclusive, Psychedelics, Top Story Cannabinoids and tryptamines have the potential to treat a wide range of diseases, which has generated significant interest among pharmaceutical companies in accessing purified compounds. Unfortunately, these compounds are often created in agricultural or chemical synthesis processes that are... Read more
